» Articles » PMID: 29451216

Does Combined Therapy of Curcumin and Epigallocatechin Gallate Have a Synergistic Neuroprotective Effect Against Spinal Cord Injury?

Overview
Date 2018 Feb 17
PMID 29451216
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Systematic inflammatory response after spinal cord injury (SCI) is one of the factors leading to lesion development and a profound degree of functional loss. Anti-inflammatory compounds, such as curcumin and epigallocatechin gallate (EGCG) are known for their neuroprotective effects. In this study, we investigated the effect of combined therapy of curcumin and EGCG in a rat model of acute SCI induced by balloon compression. Immediately after SCI, rats received curcumin, EGCG, curcumin + EGCG or saline [daily intraperitoneal doses (curcumin, 6 mg/kg; EGCG 17 mg/kg)] and weekly intramuscular doses (curcumin, 60 mg/kg; EGCG 17 mg/kg)] for 28 days. Rats were evaluated using behavioral tests (the Basso, Beattie, and Bresnahan (BBB) open-field locomotor test, flat beam test). Spinal cord tissue was analyzed using histological methods (Luxol Blue-cresyl violet staining) and immunohistochemistry (anti-glial fibrillary acidic protein, anti-growth associated protein 43). Cytokine levels (interleukin-1β, interleukin-4, interleukin-2, interleukin-6, macrophage inflammatory protein 1-alpha, and RANTES) were measured using Luminex assay. Quantitative polymerase chain reaction was performed to determine the relative expression of genes (Sort1, Fgf2, Irf5, Mrc1, Olig2, Casp3, Gap43, Gfap, Vegf, NfκB, Cntf) related to regenerative processes in injured spinal cord. We found that all treatments displayed significant behavioral recovery, with no obvious synergistic effect after combined therapy of curcumin and ECGC. Curcumin and EGCG alone or in combination increased axonal sprouting, decreased glial scar formation, and altered the levels of macrophage inflammatory protein 1-alpha, interleukin-1β, interleukin-4 and interleukin-6 cytokines. These results imply that although the expected synergistic response of this combined therapy was less obvious, aspects of tissue regeneration and immune responses in severe SCI were evident.

Citing Articles

Therapeutic potential of flavonoids in neuroprotection: brain and spinal cord injury focus.

Faysal M, Al Amin M, Zehravi M, Sweilam S, Arjun U, Gupta J Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 40014123 DOI: 10.1007/s00210-025-03888-4.


Mechanistic insight of curcumin: a potential pharmacological candidate for epilepsy.

Khatoon S, Kalam N Front Pharmacol. 2025; 15():1531288.

PMID: 39845785 PMC: 11752882. DOI: 10.3389/fphar.2024.1531288.


Epigallocatechin 3-gallate-induced neuroprotection in neurodegenerative diseases: molecular mechanisms and clinical insights.

Islam M, Rauf A, Akter S, Akter H, Al-Imran M, Islam S Mol Cell Biochem. 2025; .

PMID: 39832108 DOI: 10.1007/s11010-025-05211-4.


Curcumin/pEGCG-encapsulated nanoparticles enhance spinal cord injury recovery by regulating CD74 to alleviate oxidative stress and inflammation.

Chen T, Wan L, Xiao Y, Wang K, Wu P, Li C J Nanobiotechnology. 2024; 22(1):653.

PMID: 39443923 PMC: 11515499. DOI: 10.1186/s12951-024-02916-4.


Combinatorial therapies for spinal cord injury repair.

Sousa C, Monteiro A, Salgado A, Silva N Neural Regen Res. 2024; 20(5):1293-1308.

PMID: 38845223 PMC: 11624878. DOI: 10.4103/NRR.NRR-D-24-00061.


References
1.
Renno W, Al-Maghrebi M, Rao M, Khraishah H . (-)-Epigallocatechin-3-gallate modulates spinal cord neuronal degeneration by enhancing growth-associated protein 43, B-cell lymphoma 2, and decreasing B-cell lymphoma 2-associated x protein expression after sciatic nerve crush injury. J Neurotrauma. 2014; 32(3):170-84. PMC: 4298756. DOI: 10.1089/neu.2014.3491. View

2.
Hoppe J, Coradini K, Frozza R, Oliveira C, Meneghetti A, Bernardi A . Free and nanoencapsulated curcumin suppress β-amyloid-induced cognitive impairments in rats: involvement of BDNF and Akt/GSK-3β signaling pathway. Neurobiol Learn Mem. 2013; 106:134-44. DOI: 10.1016/j.nlm.2013.08.001. View

3.
Metin Sanli A, Turkoglu E, Serbes G, Sargon M, Besalti O, Kilinc K . Effect of curcumin on lipid peroxidation, early ultrastructural findings and neurological recovery after experimental spinal cord contusion injury in rats. Turk Neurosurg. 2012; 22(2):189-95. DOI: 10.5137/1019-5149.JTN.5193-11.1. View

4.
Gokce E, Kahveci R, Gokce A, Sargon M, Kisa U, Aksoy N . Curcumin Attenuates Inflammation, Oxidative Stress, and Ultrastructural Damage Induced by Spinal Cord Ischemia-Reperfusion Injury in Rats. J Stroke Cerebrovasc Dis. 2016; 25(5):1196-1207. DOI: 10.1016/j.jstrokecerebrovasdis.2016.01.008. View

5.
Khalatbary A, Ahmadvand H . Anti-inflammatory effect of the epigallocatechin gallate following spinal cord trauma in rat. Iran Biomed J. 2011; 15(1-2):31-7. PMC: 3639740. View